Currently, out of the existing stock ratings of Jessica Tassan - 16 which are a Hold (22.22%), 3 which are a Sell (4.17%), 53 which are a Buy (73.61%)

Jessica Tassan

Work Performance Price Targets & Ratings Chart

Analyst Jessica Tassan works at PIPER SANDLER and is covering the Healthcare sector with 134 price targets and ratings displayed on 16 stocks.

Jessica Tassan's average stock forecast success ratio is 42.71% with an average time for price targets to be met of 55.56 days.

Most recent stock forecast was given on HCAT, Health Catalyst at 13-Nov-2023.

Wall Street Analyst Jessica Tassan

Analyst best performing recommendations are on HCAT (HEALTH CATALYST).
The best stock recommendation documented was for HCAT (HEALTH CATALYST) at 9/13/2022. The price target of $11 was fulfilled within 1 day with a profit of $0.28 (2.61%) receiving and performance score of 26.12.

Average potential price target upside

CANO CMAX HCAT Health Catalyst SGFY Signify Health TRHC Tabula Rasa HealthCare CHNG Change Healthcare EVH Evolent Health OMCL Omnicell OSH Oak Street Health PHR Phreesia TDOC Teladoc Health ALHC Alignment Healthcare PRVA Privia Health Group AMWL American Well DOCS MDRX Allscripts Healthcare Solutions

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score



$-4.65 (-55.36%)


18 days ago

2/3 (66.67%)

$-1.25 (-12.56%)




$0.25 (100.00%)


3 months 21 days ago

0/5 (0%)

$3.12 (70.54%)



$0.55 (220.00%)


3 months 24 days ago

0/3 (0%)

$3.48 (64.74%)



3 months 24 days ago

0/1 (0%)

$4.88 (40.26%)


8 months 2 days ago

4/4 (100%)

$3.84 (71.44%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Jessica Tassan is most bullish on?

Potential upside of $24.82 has been obtained for PHR (PHREESIA)

Which stock is Jessica Tassan is most reserved on?

Potential downside of -$1.54 has been obtained for DOCS

What Year was the first public recommendation made by Jessica Tassan?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart